Sucrase-isomaltase deficiency, is a congenital genetic disorder that results in a person’s disability in digesting various kinds of sugar such as maltose and sucrose.
In patients with Congenital Sucrase-Isomaltase Deficiency (CSID) and gastrointestinal symptoms that warrant treatment, three major treatment options exist which include, Severe diet restriction, Sucraid® (sacrosidase) Oral Solution and Sucraid with moderate diet restriction.
The following is the treatment for Sucrase-isomaltase deficiency, congenital.
- Low sugar diet: since the SI gene is disturbed by the improper function of enzyme sucrase-isomaltase present in the small intestine and is responsible for breaking down sucrose and maltose into their simple sugar components. So, it is advised that a child should limit the intake of food that have fructose, maltose, sucrose, and other types of sugar. However, it is advised to appoint a dietician so the daily intake of sugar to keep blood sugar level stable.
- Sucraid: Sucrosidases oral solution recommended for patients dealing with congenital sucrase-isomaltase deficiency. It is used to treat sucrase deficiency. It is an FDA-approved drug used for oral enzyme replacement therapy for genetically determined sucrase deficiency. Since, Sucrase-isomaltase deficiency, congenital is a genetic disorder, it isn’t properly curable but can be restricted through medications.
Improper digestion of sugar such as maltose and sucrose,A mutation in the gene
Stomach cramps,Diarrhea,Excess gas production,Vomiting,Bloating